Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-29T01:11:07.437Z Has data issue: false hasContentIssue false

12 - The Lazarus Effect: the (RED) Campaign and creative capitalism

Published online by Cambridge University Press:  04 August 2010

Thomas Pogge
Affiliation:
Yale University, Connecticut
Matthew Rimmer
Affiliation:
Australian National University, Canberra
Kim Rubenstein
Affiliation:
Australian National University, Canberra
Get access

Summary

Introduction

4,400 people die every day of AIDS in sub-Saharan Africa. Treatment exists. In about 60 days, a patient can go from here to here. We call this transformation the Lazarus Effect. It is the result of two pills a day taken by a HIV/AIDS patient for about 60 days. Learn more about how you can help give people the chance of life and joinred.com.

The Lazarus Effect video, the (RED) Campaign

In the recent literature, there has been much critical discussion about the role of patent law in promoting research and development in respect of neglected diseases. There has also been much exploration of alternative mechanisms – such as prizes, the Health Impact Fund, patent pools, Open Source drug discovery and priority review mechanisms – to encourage innovation in respect of essential medicines.

A number of non-government organizations, charities and philanthropists have promoted ‘grants’ as a means of stimulating investment in research and development into neglected diseases. The (RED) Campaign has been designed to boost private funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria (‘The Global Fund’). The Bill & Melinda Gates Foundation (‘Gates Foundation’), and the William J. Clinton Foundation (‘Clinton Foundation’) have played an important role in funding research and development in respect of infectious diseases. It is worthwhile analysing the ways in which such charities, foundations and philanthropists have sought to deploy trade-marks, celebrity endorsements and corporate social responsibility to promote access to medicines.

Type
Chapter
Information
Incentives for Global Public Health
Patent Law and Access to Essential Medicines
, pp. 313 - 340
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×